JPH09295928A - Cosmetic material for prevention of aging - Google Patents

Cosmetic material for prevention of aging

Info

Publication number
JPH09295928A
JPH09295928A JP8110822A JP11082296A JPH09295928A JP H09295928 A JPH09295928 A JP H09295928A JP 8110822 A JP8110822 A JP 8110822A JP 11082296 A JP11082296 A JP 11082296A JP H09295928 A JPH09295928 A JP H09295928A
Authority
JP
Japan
Prior art keywords
skin
extract
hibiscus
aging
collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8110822A
Other languages
Japanese (ja)
Other versions
JP3748941B2 (en
Inventor
Mariko Funagai
真理子 舟貝
Hiroshi Toyama
洋 遠山
Michiyo Sakota
三千代 迫田
Yuki Handa
由希 半田
Kazuhiro Suetsugu
一博 末次
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NARISU COSMETIC CO Ltd
NARISU KESHOHIN KK
Original Assignee
NARISU COSMETIC CO Ltd
NARISU KESHOHIN KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NARISU COSMETIC CO Ltd, NARISU KESHOHIN KK filed Critical NARISU COSMETIC CO Ltd
Priority to JP11082296A priority Critical patent/JP3748941B2/en
Publication of JPH09295928A publication Critical patent/JPH09295928A/en
Application granted granted Critical
Publication of JP3748941B2 publication Critical patent/JP3748941B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the above cosmetic material improving a tenseness/wrinkle of a skin by activating the proliferation of dermal fibroblast cells and increasing the production of an extracellular matrix. SOLUTION: This cosmetic material for the prevention of aging, contains Hibiscus sabdariffa L., itself or an extract with an organic solvent and/or water. This plant extract is obtained by extracting a dried and powdered hibiscus, etc., with an aqueous alcohol, etc., usually at 4-100 deg.C. The amount of blending is optional, and in accordance with an object, 0.001-100wt.% extract is blended and used. The extract increases the amount of collagen in the skin of a mouse.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、皮膚線維芽細胞の増殖
を活性化し、細胞外マトリックス産生を増加させること
により、皮膚のはり・しわを改善する皮膚老化防止効果
に優れた老化防止化粧料に関する。
FIELD OF THE INVENTION The present invention relates to an anti-aging cosmetic composition which has an excellent anti-aging effect on skin by improving the skin's scalp and wrinkles by activating the proliferation of skin fibroblasts and increasing extracellular matrix production. Regarding

【0002】[0002]

【従来の技術および課題】近年、健康で美しい肌を保つ
ことが、老若男女を問わず、重大な関心事になってい
る。ところが、肌は、加齢などの内的因子や紫外線、活
性酸素などの外的因子によって、皮膚が本来維持してい
る収縮性、柔軟性、保湿性などの機能が衰え、様々なト
ラブルを発生する。これらのトラブルのひとつであるし
わは、真皮の細胞外マトリックスを産生する細胞数の減
少、***速度の衰えなどの細胞機能の老化や、コラーゲ
ン線維の減少および変性、皮下脂肪組織の減少などによ
り、皮膚の弛緩および弾力性の損失が起こることが原因
となって発生する。従来、皮膚老化への対処法として
は、老化によって失われるコラーゲン、ヒアルロン酸な
どの物質を皮膚に塗布し補う組成物や、紫外線や活性酸
素から皮膚を守るための防御物質を配合した間接的な老
化防止剤が主流であった。
2. Description of the Related Art In recent years, maintaining healthy and beautiful skin has become a serious concern for people of all ages. However, due to internal factors such as aging and external factors such as ultraviolet rays and active oxygen, the skin's originally maintained functions such as contractility, flexibility, and moisturizing properties decline, causing various problems. To do. Wrinkles, which are one of these problems, are due to a decrease in the number of cells that produce the extracellular matrix of the dermis, aging of cell functions such as a decline in the division rate, reduction and degeneration of collagen fibers, and reduction of subcutaneous adipose tissue. It is caused by loosening of the skin and loss of elasticity. Conventionally, as a method for coping with skin aging, collagen that is lost due to aging, a composition that applies and supplements substances such as hyaluronic acid to the skin, and an indirect mixture of a protective substance to protect the skin from ultraviolet rays and active oxygen Anti-aging agents were the mainstream.

【0003】[0003]

【発明者が解決しようとする課題】しかしながらこれら
の方法は満足のいく効果を奏するものではなかった。ま
た、老化を根本的に改善しようとする試みとしてはレチ
ノイン酸などがあるが、安全性に問題があり、長期使用
に耐え得るものではなかった。従って、皮膚の老化を改
善し、しかも皮膚に弊害がなく、安全に使用できる老化
防止化粧料の開発が望まれている。
However, these methods have not achieved satisfactory effects. In addition, there are retinoic acid and the like as an attempt to fundamentally improve the aging, but there is a problem in safety and it cannot be used for a long time. Therefore, there is a demand for the development of an anti-aging cosmetic composition that improves the aging of the skin, has no harmful effect on the skin, and can be used safely.

【0004】[0004]

【問題を解決する手段】そこで本発明者らは、かかる実
情に鑑み鋭意検討した結果、ハイビスカス自体又はその
有機溶媒及び/又は水による抽出物が、皮膚線維芽細胞
の細胞増殖を活性化し、細胞外マトリックスの産生を増
加させることにより、皮膚のはり・しわの改善に顕著な
作用を示すことを見出し、本発明を完成するに至った。
[Means for Solving the Problems] Therefore, as a result of intensive investigations by the present inventors in view of such circumstances, hibiscus itself or an extract thereof with an organic solvent and / or water activates cell proliferation of skin fibroblasts, It has been found that increasing the production of the outer matrix exerts a remarkable effect on the improvement of the skin's elasticity and wrinkles, and has completed the present invention.

【0005】すなわち、本発明は、ハイビスカス自体又
はその有機溶媒及び/又は水による抽出物を含有するこ
とを特徴とする老化防止化粧料を提供するものである。
That is, the present invention provides an anti-aging cosmetic composition which contains hibiscus itself or an extract thereof with an organic solvent and / or water.

【0006】本発明で使用されるハイビスカス(学名:
Hibiscus sabdariffa L.)は通常、各種溶剤で抽出し、
抽出物(エキス)として使用するが、抽出液をそのまま
使用してもよいし、乾燥粉体として使用してもよい。ま
た、ハイビスカスをそのまま小片に裁断して小片状で使
用しても、或いは乾燥後、粉砕して粉末状で使用しても
よい。
Hibiscus used in the present invention (scientific name:
Hibiscus sabdariffa L.) is usually extracted with various solvents,
Although it is used as an extract, the extract may be used as it is or may be used as a dry powder. Further, the hibiscus may be cut into small pieces as they are and used in the form of small pieces, or may be dried and then pulverized and used in the form of powder.

【0007】ここで前記抽出物を得る方法としては公知
の方法が利用できる。植物抽出物は上記ハイビスカス、
好ましくは乾燥末化したものを水もしくは有機溶媒(ヘ
キサン、エーテル、酢酸エチル、ブタノール、アセト
ン、プロパノール、エタノール、メタノール、プロピレ
ングリコール、1,3ブチレングリコール)あるいはそれ
らを一定の比率で混合した溶媒、たとえば水性アルコー
ルを用い、通常4℃〜100℃で抽出して得られる。こうし
て得られた抽出物は、必要に応じて活性炭又は活性白土
等により精製する。一般的には配合量は目的に応じ、0.
001〜100重量%を任意に配合、使用する。
Here, a known method can be used as a method for obtaining the extract. The plant extract is the above hibiscus,
Preferably dried powder is water or an organic solvent (hexane, ether, ethyl acetate, butanol, acetone, propanol, ethanol, methanol, propylene glycol, 1,3 butylene glycol) or a solvent obtained by mixing them in a certain ratio, For example, it is usually obtained by extraction with aqueous alcohol at 4 ° C to 100 ° C. The extract thus obtained is purified with activated carbon, activated clay or the like, if necessary. Generally, the blending amount is 0 depending on the purpose.
001 to 100% by weight is arbitrarily blended and used.

【0008】[0008]

【実施例】以下、実施例により本発明を詳細に説明する
が、本発明はこれらに限定されるものではない。
The present invention will be described below in detail with reference to examples, but the present invention is not limited to these examples.

【0009】(ハイビスカス抽出物 製造例) 原材料
として、ハイビスカスの乾燥物を300g使用した。前記原
材料300gにイオン交換水450mlを加え、60℃で3時間加熱
抽出した後No.2濾紙にて濾過する。全ての濾液を合わ
せ、HP-20(三菱化成社製:φ=50mm,h=500mm)カラムク
ロマトグラフィーに付し、HP-20未吸着画分を、ロータ
リーエバポレーターにて減圧濃縮、凍結乾燥し、ハイビ
スカス抽出物120gを得た(収量40%)。
(Hibiscus Extract Production Example) 300 g of dried hibiscus was used as a raw material. Ion-exchanged water (450 ml) is added to the raw material (300 g), and the mixture is heated and extracted at 60 ° C. for 3 hours, and then filtered with No. 2 filter paper. All the filtrates were combined and subjected to HP-20 (Mitsubishi Kasei: φ = 50 mm, h = 500 mm) column chromatography, HP-20 unadsorbed fraction was concentrated under reduced pressure by a rotary evaporator and freeze-dried, 120 g of hibiscus extract was obtained (yield 40%).

【0010】<実験例1>皮膚線維芽細胞増殖試験 (1)試験溶液調製 前記ハイビスカス抽出物をCa2+,Mg2+不含有PBS(phosph
ate buffered saline。蒸留水1lあたり、NaCl 8.0g, K
Cl 0.2g, KH2PO4 0.2g, Na2HPO4・12H20 2.9g)に0.1(w
/v)%になるように溶解後、0.2μmメンブランフィルタ
ーにて濾過滅菌し、適宜希釈したものを、試験溶液とし
た。 (2)細胞培養 正常ヒト2倍体線維芽細胞HFSKF-II(理化学研究所製)
を、Ham-F12(大日本製薬社製)に15(v/v)%の牛胎児
血清を添加したもので培養した。前記培地にて1×105c
ell/mlに調整した細胞を、内径16mmの滅菌プラスチック
24穴プレートに0.5mlずつ接種し、24時間培養後、試験
溶液を10(v/v)%含む培地に交換し、その後48時間培
養した。 (3)細胞数測定 前記のように培養後、24穴プレートの培地を捨て、C
a2+,Mg2+不含有PBSで細胞を洗浄後、トリプシンを用い
て細胞を剥離し、細胞数を測定し、細胞増殖作用を検討
した。これらの結果を第1表に示す。なお、ネガティブ
コントロールとしてはCa2+,Mg2+不含有PBSを用いた。
<Experimental example 1> Skin fibroblast proliferation test (1) Preparation of test solution The hibiscus extract was Ca 2 +- , Mg 2 + -free PBS (phosph)
ate buffered saline. 8.0 g, K NaCl per liter of distilled water
Cl 0.2g, KH 2 PO 4 0.2g, Na 2 HPO 4・ 12H 2 0 2.9g) 0.1 (w
/ v)% and then sterilized by filtration through a 0.2 μm membrane filter and appropriately diluted to obtain a test solution. (2) Cell culture Normal human diploid fibroblast HFSKF-II (manufactured by RIKEN)
Were cultured in Ham-F12 (Dainippon Pharmaceutical Co., Ltd.) supplemented with 15 (v / v)% fetal bovine serum. 1 × 10 5 c in the above medium
Cells prepared to ell / ml were treated with sterile plastic with an inner diameter of 16 mm.
0.5 ml each was inoculated into a 24-well plate, and after culturing for 24 hours, the test solution was replaced with a medium containing 10 (v / v)%, and then culturing was continued for 48 hours. (3) Cell number measurement After culturing as described above, the medium in the 24-well plate is discarded, and C
a 2+, cells were washed with Mg 2+-free PBS, the cells were detached using trypsin, and cell number determined, were examined cell proliferation effect. Table 1 shows the results. As a negative control, PBS without Ca 2+ and Mg 2+ was used.

【0011】[0011]

【表1】皮膚線維芽細胞増殖試験結果 濃度(ppm) 細胞数 対Control(%) Control 100 10 112 50 153 100 130[Table 1] Skin fibroblast proliferation test results Concentration (ppm) Number of cells vs. Control (%) Control 100 10 112 50 153 100 130

【0012】表1の結果より、前記ハイビスカス抽出物
は皮膚線維芽細胞の増殖効果を有することが見いだされ
た。
From the results shown in Table 1, it was found that the hibiscus extract had a dermal fibroblast proliferation effect.

【0013】<実験例2>皮膚線維芽細胞賦活試験 MTT(3-(4,5-シ゛メチルチアソ゛ール-2-イル)-2,5-シ゛フェニルーテトラソ゛リウムフ
゛ロマイト゛)は生細胞中に取り込まれるとミトコンドリア中
の酵素の作用を間接的に受けてTetrazolium環が還元的
に開裂し、青色のFormazanを形成する。細胞中で生成さ
れるFormazan量は細胞のミトコンドリアのエネルギー代
謝(呼吸酵素活性)と良好な相関があるため、MTT還元
法によって細胞賦活効果を評価できる。 (1)試験溶液調製 前記ハイビスカス抽出物をCa2+,Mg2+不含有PBSで希釈
し、0.2μmメンブランフィルターにて濾過滅菌したもの
を、試験溶液とした。 (2)MTTストック溶液の調製 MTT(3-(4,5-シ゛メチルチアソ゛ール-2-イル)-2,5-シ゛フェニルーテトラソ゛リウムフ
゛ロマイト゛)5mgをCa2+,Mg 2+不含有PBS 1mlに溶解した溶液
をフィルターで濾過後、滅菌してMTTストック溶液を調
製した。 (3)細胞培養 正常ヒト2倍体線維芽細胞HFSKF-IIを、Ham-F12(大日
本製薬社製)に15(v/v)%の牛胎児血清を添加したも
ので培養した。前記培地にて1×105cell/mlに調整した
細胞を、内径16mmの滅菌プラスチック24穴プレートに0.
5mlずつ接種し、24時間培養後、試験溶液を10(v/v)%
含む培地に交換し、その後48時間培養した。24穴プレー
トの培地を捨て、Ca2+,Mg2+不含有PBSで細胞を洗浄後、
前記MTTストック溶液を10mlMTTストック/100μl培地と
なるように加え、4時間培養した。培地を除去し、酸性
イソプロパノール(特級塩酸を0.04Nになるようイソプ
ロパノールに添加した溶液)を各ウェルに600μl添加、
攪拌後、波長570nmで吸光度を測定し、波長650nmで測定
した濁度の吸光度を差し引いてFormazanの生成量として
評価した。これらの結果を表2に示す。なお、ネガティ
ブコントロールとしてはCa2+,Mg2+不含有PBSを用いた。
<Experimental example 2> Skin fibroblast activation test MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl-tetrazolium fluoride
“Chromide” is taken up by mitochondria in living cells.
Tetrazolium ring is reductively affected by the action of various enzymes
Cleaves to form a blue Formazan. Produced in cells
The amount of Formazan stored is the energy cost of the mitochondria of cells.
MTT reduction due to good correlation with Xie (respiratory enzyme activity)
The cell activation effect can be evaluated by the method. (1) Preparation of test solution The hibiscus extract was replaced with Ca.2+, Mg2+Diluted with PBS containing no
And sterilized by filtration with a 0.2 μm membrane filter
Was used as the test solution. (2) Preparation of MTT stock solution MTT (3- (4,5-Dimethylthiazol-2-yl) -2,5-diphenyltetrazolium fluoride
5 mg of Ca)2+, Mg 2+Solution dissolved in PBS containing 1 ml
After filtering with a filter, sterilize and prepare the MTT stock solution.
Made. (3) Cell culture Normal human diploid fibroblasts HFSKF-II were transformed into Ham-F12 (Dainichi
15 (v / v)% fetal bovine serum was added to this pharmaceutical company)
So it was cultivated. 1 x 10 in the above mediumFiveadjusted to cell / ml
Cells are placed in a sterile plastic 24-well plate with an inner diameter of 16 mm.
Inoculate 5 ml each, and after culturing for 24 hours, test solution 10 (v / v)%
The medium was replaced with a medium containing the cells, and then the cells were cultured for 48 hours. 24-hole play
Discard the culture medium of2+, Mg2+After washing the cells with PBS containing no
The MTT stock solution was mixed with 10 ml MTT stock / 100 μl medium.
And added for 4 hours. Remove medium and acid
Isopropanol (Special grade hydrochloric acid is adjusted to 0.04N
600 μl added to each well).
After stirring, measure the absorbance at a wavelength of 570 nm and at a wavelength of 650 nm
Subtract the absorbance of the turbidity
evaluated. Table 2 shows the results. Negati
Ca as a control2+, Mg2+Non-containing PBS was used.

【0014】[0014]

【表2】皮膚線維芽細胞賦活試験結果 濃度(ppm) エネルギー代謝率 対Control(%) Control 100 50 107 100 113 200 121[Table 2] Skin fibroblast activation test results Concentration (ppm) Energy metabolism rate Control (%) Control 100 50 107 100 113 200 121

【0015】表2の結果より、前記ハイビスカス抽出物
は線維芽細胞賦活効果を有することが見いだされた。
From the results shown in Table 2, it was found that the hibiscus extract had a fibroblast activating effect.

【0016】<実験例3>皮膚線維芽細胞コラーゲン合
成促進試験 (1)試験溶液調製 前記ハイビスカス抽出物をCa2+,Mg2+不含有PBSで希釈
し、0.2μmメンブランフィルターにて濾過滅菌したもの
を、試験溶液とした。 (2)細胞培養 正常ヒト2倍体線維芽細胞HFSKF-IIを、Ham-F12(大日
本製薬社製)に15(v/v)%の牛胎児血清を添加したも
ので培養した。前記培地にて1×105cell/mlに調整した
細胞を、内径32mmの滅菌プラスチック12穴プレートに1.
0mlずつ接種し、120時間培養後、試験溶液を10(v/v)
%含む無血清線維芽細胞増殖培地F-GM(クラボウ社製)
に交換し、その後48時間培養を行った。 (3)細胞数の測定 前記のように培養後、12穴シャーレの培地を捨て、C
a2+,Mg2+不含有PBSで細胞を洗浄し、トリプシンを用い
て細胞を剥離し、細胞数を測定した。試験溶液のネガテ
ィブコントロールとしてはCa2+,Mg2+不含有PBSを使用し
た。 (4)培地内コラーゲン量の測定 培地内コラーゲン量は、前記(2)のように培養後、12
穴プレートの各ウェルの培地を採取し、Ca2+,Mg2+不含
有PBSにより細胞を洗浄した液を加えた溶液中に存在す
るヒドロキシプロリンの含量を定量することにより測定
した。ヒドロキシプロリンはコラーゲンに特徴的なアミ
ノ酸である。ヒドロキシプロリン量は、Inayama,Shibat
a,Ohtuki,Saitoの方法(藤本大三郎、永井裕(1985)、コラ
ーケ゛ン実験法、pp.51-56、講談社)に準じ、以下の方法に
より測定した。まず、培地に等容の12N-HClを加え、110
℃、24時間加熱する。加水分解後、HClはロータリーエ
バポレーターで除去しておく。蒸留水2ml、KCl 1.5g、
ホウ酸緩衝液(蒸留水1l当たり、ホウ酸 61.84g、KCl 2
25g、pH8.7)0.5mlを加え、室温で20分間静置する。ク
ロラミンT溶液(p-トルエンスルホンクロロアミドナト
リウム三水和物 1.41gを2ーメトキシエタノール25mlに溶
解)0.5mlを加えて25分間適宜振とうし、さらに3.6Mチ
オ硫酸ナトリウム溶液 1.5mlを加え、密栓し、100℃で3
0分間加熱する。冷却した後、トルエンを2.5ml加え5分
間振とう後、トルエン層を採取し、無水硫酸ナトリウム
のカラム(6mm2×30mm)を通過させる。流出液1.0mlを
とり、p-ジメチルアミノベンズアルデヒド溶液 0.5ml
(p-ジメチルアミノベンズアルデヒド 120gをエタノー
ル 200mlに溶解した液と、濃硫酸 27.4mlをエタノール
200mlに溶解した液を、氷冷下で混合)と混合し、室温
で30分間放置後、560nmの吸光度を測定する。 コラーゲ
ン量を前記(3)で測定した細胞数で割り、細胞数あた
りの培地内コラーゲン量を算出する。試験溶液のネガテ
ィブコントロールとしてはCa2+,Mg2+不含有PBSを使用し
た。コラーゲン合成促進率は次式を用い、ネガティブコ
ントロールのコラーゲン量を100%として計算を行った。
<Experimental Example 3> Skin fibroblast collagen synthesis promotion test (1) Preparation of test solution The hibiscus extract was diluted with Ca 2+ and Mg 2 + -free PBS and sterilized by filtration with a 0.2 μm membrane filter. Was used as the test solution. (2) Cell culture Normal human diploid fibroblasts HFSKF-II were cultured in Ham-F12 (Dainippon Pharmaceutical Co., Ltd.) supplemented with 15 (v / v)% fetal bovine serum. The cells adjusted to 1 × 10 5 cells / ml with the above medium were placed on a sterile plastic 12-well plate with an inner diameter of 32 mm.
Inoculate 0 ml each and incubate for 120 hours, then test solution 10 (v / v)
% Serum-free fibroblast growth medium F-GM (Kurabo)
After that, the cells were cultured for 48 hours. (3) Measurement of cell number After culturing as described above, the medium of the 12-well petri dish was discarded, and C
a 2+, cells were washed with Mg 2+-free PBS, the cells were detached using trypsin and cell numbers were determined. As a negative control of the test solution, PBS without Ca 2+ and Mg 2+ was used. (4) Measurement of the amount of collagen in the medium The amount of collagen in the medium was 12 after culturing as described in (2) above.
The medium of each well of the well plate was collected, and the content of hydroxyproline present in the solution to which the solution obtained by washing the cells with Ca 2 + , Mg 2 + -free PBS was added was quantified and measured. Hydroxyproline is a characteristic amino acid in collagen. The amount of hydroxyproline is Inayama, Shibat
According to the method of a, Ohtuki, Saito (Daisaburo Fujimoto, Yu Nagai (1985), Collagen Experimental Method, pp.51-56, Kodansha), the measurement was carried out by the following method. First, add an equal volume of 12N-HCl to the medium and
Heat at ℃ for 24 hours. After hydrolysis, HCl is removed on a rotary evaporator. 2 ml distilled water, 1.5 g KCl,
Borate buffer solution (per 1 liter of distilled water, boric acid 61.84 g, KCl 2
Add 25 g, pH 8.7) 0.5 ml and let stand at room temperature for 20 minutes. Add 0.5 ml of chloramine T solution (1.41 g of sodium p-toluenesulfonchloroamide trihydrate dissolved in 25 ml of 2-methoxyethanol) and shake appropriately for 25 minutes, and then add 1.5 ml of 3.6 M sodium thiosulfate solution, Seal tightly, 3 at 100 ℃
Heat for 0 minutes. After cooling, add 2.5 ml of toluene and shake for 5 minutes, collect the toluene layer, and pass through a column of anhydrous sodium sulfate (6 mm 2 × 30 mm). Take 1.0 ml of effluent and 0.5 ml of p-dimethylaminobenzaldehyde solution.
(P-dimethylaminobenzaldehyde 120 g dissolved in ethanol 200 ml and concentrated sulfuric acid 27.4 ml in ethanol
The solution dissolved in 200 ml is mixed with ice-cold mixture) and left at room temperature for 30 minutes, and then the absorbance at 560 nm is measured. The amount of collagen is divided by the number of cells measured in (3) above to calculate the amount of collagen in the medium per number of cells. As a negative control of the test solution, PBS without Ca 2+ and Mg 2+ was used. The collagen synthesis promotion rate was calculated using the following formula, with the amount of collagen in the negative control being 100%.

【0017】[0017]

【数1】培地内コラーケ゛ン合成率(%)=(Sx/Cx)× 100 Sx;試料溶液を添加したウェルにおける細胞数あたりの
培地内コラーゲン量 Cx;Ca2+,Mg2+不含有PBSを添加したウェルにおける細胞
数あたりの培地内コラーゲン量 これらの結果を表3に示す。なお、ネガティブコントロ
ールとしてはCa2+,Mg2 +不含有PBSを用いた。
[Equation 1] Collagen synthesis rate in culture medium (%) = (Sx / Cx) x 100 Sx; Collagen amount in culture medium per cell number in wells containing sample solution Cx; Ca 2+ , Mg 2+ free PBS Amount of collagen in the medium per number of cells in the added well These results are shown in Table 3. As a negative control, PBS without Ca 2+ and Mg 2 + was used.

【0018】[0018]

【表3】皮膚線維芽細胞コラーゲン合成促進試験結果 濃度(ppm)培地内コラーゲン合成率 対Control(%) Control 100 10 101 50 105 100 106[Table 3] Skin fibroblast collagen synthesis promotion test results Concentration (ppm) Collagen synthesis rate in medium Control (%) Control 100 10 101 50 105 100 106

【0019】表3の結果より、前記ハイビスカス抽出物
は皮膚線維芽細胞のコラーゲン合成促進効果を有するこ
とが見いだされた。
From the results shown in Table 3, it was found that the hibiscus extract had a collagen synthesis promoting effect on skin fibroblasts.

【実験例4】マウス皮膚塗布試験 実験動物としてICR系雌マウス(リタイア)を用い、バ
リカンにて剃毛した背部皮膚にハイビスカスエキスを10
(v/v)%エタノールに溶解した溶液を1日1回0.2ml、
5日/週、塗布した。4週間後、マウス背部から直径12m
mの皮膚を採取した。採取した皮膚はを重量を測定後、
アセトンにて脱水・脱脂後均質化し、実験例3(4)に
示したInayama,Shibata,Ohtuki,Saitoの方法(藤本大三
郎、永井裕(1985)、コラーケ゛ン実験法、pp.51-56、講談社)
に準じてコラーゲン量を算出した。これらの結果を表4
に示す。なお、ネガティブコントロールとしては10(v/
v)%エタノール溶液を用いた。
[Experimental Example 4] Mouse skin application test Using an ICR female mouse (retired) as an experimental animal, 10 parts of hibiscus extract was applied to the back skin shaved with a clipper.
0.2 ml of a solution dissolved in (v / v)% ethanol once a day,
It was applied for 5 days / week. 4m later, 12m in diameter from the back of the mouse
m skin was collected. After measuring the weight of the collected skin,
Method of Inayama, Shibata, Ohtuki, Saito shown in Experimental Example 3 (4) after dehydration and degreasing with acetone (Daisaburo Fujimoto, Yu Nagai (1985), Collagen Experimental Method, pp.51-56, Kodansha)
The amount of collagen was calculated according to. Table 4 shows these results.
Shown in As a negative control, 10 (v /
v) A% ethanol solution was used.

【0020】[0020]

【表4】マウス皮膚塗布試験結果 濃度(w/v)% 皮膚コラーゲン量 対Control(%) Control 100 5 104 10 116 20 139[Table 4] Mouse skin application test results Concentration (w / v)% Skin collagen amount vs. Control (%) Control 100 5 104 10 116 20 139

【0021】表4の結果より、前記ハイビスカス抽出物
はマウス皮膚のコラーゲン量を増加させる効果を有する
ことが見いだされた。
From the results shown in Table 4, it was found that the hibiscus extract had an effect of increasing the amount of collagen in mouse skin.

【0022】[0022]

【処方例】以下に本発明の処方例を挙げる。[Prescription example] The prescription example of the present invention is given below.

【0023】 <処方例1>化粧水 (重量%) ハイビスカスエキス 10.0 グリセリン 5.0 ポリオキシエチレンソルビタンモノラウレート(20E.0) 1.5 エタノール 10.0 防腐剤・酸化防止剤 適量 香料 適量 精製水 残部<Formulation Example 1> Lotion (% by weight) Hibiscus extract 10.0 Glycerin 5.0 Polyoxyethylene sorbitan monolaurate (20E.0) 1.5 Ethanol 10.0 Preservative / antioxidant Proper amount Perfume Proper amount Purified water balance

【0024】 <処方例2>化粧用クリーム (重量%) ハイビスカスエキス 0.1 ミツロウ 2.0 ステアリルアルコール 5.0 ステアリン酸 8.0 スクワラン 10.0 自己乳化型グリセリルモノステアレート 3.0 ポリオキシエチレンセチルエーテル(20E.0) 1.0 プロピレングリコール 5.0 水酸化カリウム 0.3 香料 適量 防腐剤・酸化防止剤 適量 精製水 残部<Formulation Example 2> Cosmetic cream (% by weight) Hibiscus extract 0.1 Beeswax 2.0 Stearyl alcohol 5.0 Stearic acid 8.0 Squalane 10.0 Self-emulsifying glyceryl monostearate 3.0 Polyoxyethylene cetyl ether (20E.0) 1.0 Propylene glycol 5.0 Potassium hydroxide 0.3 Perfume Proper amount Preservative / antioxidant Proper amount Purified water Balance

【0025】 <処方例3>乳液 (重量%) ハイビスカスエキス 5.0 スクワラン 8.0 ワセリン 2.0 ミツロウ 0.5 ソルビタンセスキオレエート 0.8 ポリオキシエチレンオレイルエーテル(20E.0) 1.2 カルボキシビニルポリマー 0.2 プロピレングリコール 0.5 水酸化カリウム 0.1 エタノール 7.0 香料 適量 防腐剤・酸化防止剤 適量 精製水 残部<Formulation Example 3> Emulsion (wt%) Hibiscus extract 5.0 Squalane 8.0 Vaseline 2.0 Beeswax 0.5 Sorbitan sesquioleate 0.8 Polyoxyethylene oleyl ether (20E.0) 1.2 Carboxyvinyl polymer 0.2 Propylene glycol 0.5 Potassium hydroxide 0.1 Ethanol 7.0 Fragrance Suitable amount Preservative / antioxidant Suitable amount Purified water Remainder

【0026】 <処方例4>パック剤 (重量%) ハイビスカスエキス 1.0 酢酸ビニル樹脂エマルジョン 15.0 ポリビニルアルコール 10.0 オリーブ油 3.0 グリセリン 5.0 酸化チタン 8.0 カオリン 7.0 エタノール 5.0 香料 適量 防腐剤・酸化防止剤 適量 精製水 残部<Formulation Example 4> Packing agent (% by weight) Hibiscus extract 1.0 Vinyl acetate resin emulsion 15.0 Polyvinyl alcohol 10.0 Olive oil 3.0 Glycerin 5.0 Titanium oxide 8.0 Kaolin 7.0 Ethanol 5.0 Perfume proper amount Preservative / antioxidant proper amount Purified water balance

【0027】 <処方例5>軟膏 (重量%) ハイビスカスエキス 0.5 酢酸トコフェロール 0.5 パラジメチルアミノ安息香酸オクチル 4.0 ブチルメトキシベンゾイルメタン 4.0 ステアリルアルコール 18.0 モクロウ 20.0 グリセリンモノステアリン酸エステル 0.3 ワセリン 33.0 香料 適量 防腐剤・酸化防止剤 適量 精製水 残部<Prescription Example 5> Ointment (% by weight) Hibiscus extract 0.5 Tocopherol acetate 0.5 Octyl dimethyl parabenzoylbenzoate 4.0 Butylmethoxybenzoylmethane 4.0 Stearyl alcohol 18.0 Mokurou 20.0 Glycerin monostearate 0.3 Vaseline 33.0 Perfume Proper preservative / oxidation Inhibitor Suitable amount Purified water Balance

【0028】[0028]

【発明の効果】本発明によれば、ハイビスカス自体又は
その有機溶媒及び/又は水による抽出物を含有した安全
な老化防止化粧料が提供され、該老化防止化粧料は皮膚
全体の老化を根本的に改善することができるため、いつ
までもみずみずしくはりのある肌を保つことができる。
EFFECTS OF THE INVENTION According to the present invention, there is provided a safe anti-aging cosmetic composition containing hibiscus itself or an extract thereof with an organic solvent and / or water. Because it can be improved, you can keep fresh and supple skin forever.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 半田 由希 大阪市福島区海老江1丁目11番17号 株式 会社ナリス化粧品内 (72)発明者 末次 一博 大阪市福島区海老江1丁目11番17号 株式 会社ナリス化粧品内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yuki Handa 1-11-17 Ebie, Fukushima-ku, Osaka City Naris Cosmetics Co., Ltd. (72) Inventor Kazuhiro Suetsugu 1-11-17 Ebie, Fukushima-ku, Osaka Stocks Company Naris Cosmetics

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】ハイビスカス自体又はその有機溶媒及び/
又は水による抽出物を含有することを特徴とする老化防
止化粧料。
1. Hibiscus itself or its organic solvent and / or
Alternatively, an anti-aging cosmetic composition comprising an extract with water.
【請求項2】ハイビスカス自体又はその有機溶媒及び/
又は水による抽出物を含有し、皮膚のはり・しわを改善
することを特徴とする老化防止化粧料。
2. Hibiscus itself or its organic solvent and / or
Alternatively, an anti-aging cosmetic composition containing an extract from water to improve the skin's elasticity and wrinkles.
JP11082296A 1996-05-01 1996-05-01 Anti-aging cosmetic Expired - Lifetime JP3748941B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11082296A JP3748941B2 (en) 1996-05-01 1996-05-01 Anti-aging cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11082296A JP3748941B2 (en) 1996-05-01 1996-05-01 Anti-aging cosmetic

Publications (2)

Publication Number Publication Date
JPH09295928A true JPH09295928A (en) 1997-11-18
JP3748941B2 JP3748941B2 (en) 2006-02-22

Family

ID=14545546

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11082296A Expired - Lifetime JP3748941B2 (en) 1996-05-01 1996-05-01 Anti-aging cosmetic

Country Status (1)

Country Link
JP (1) JP3748941B2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1036279A (en) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd Fibroblast proliferation promoting agent containing vegetable extract
JP2001151630A (en) * 1999-11-30 2001-06-05 Kanebo Ltd Cosmetic
KR100330137B1 (en) * 1999-07-16 2002-03-27 복성해 Novel triterpene-series chemical compound capable of inhibiting lipid-peroxidation and process for preparation thereof
JP2004359632A (en) * 2003-06-06 2004-12-24 Naris Cosmetics Co Ltd External preparation for skin
US6849278B2 (en) * 2001-11-21 2005-02-01 Universal Biotech Co., Ltd. Method to counter oxidation of LDL, decrease triglyceride or cholesterol and inhibit atherosclerosis using Hibiscus sabdariffa extract
WO2006106993A1 (en) * 2005-03-31 2006-10-12 Kobayashi Pharmaceutical Co., Ltd. Melanogenesis inhibitor
WO2006106992A1 (en) * 2005-03-31 2006-10-12 Kobayashi Pharmaceutical Co., Ltd. Melanin production inhibitory agent
JP2006347925A (en) * 2005-06-14 2006-12-28 Kyoei Kagaku Kogyo Kk Plant fermentation product and cosmetic containing the same
WO2008029798A1 (en) * 2006-09-06 2008-03-13 Noevir Co., Ltd. Cell activator, collagen production promoter, skin whitening agent, antioxidant agent, antiinflammatory agent, aromatase activity promoter, protease activity promoter, external preparation for skin, and food
US20130302279A1 (en) * 2012-04-20 2013-11-14 University Of Medicine & Dentistry Of New Jersey Identification of natural plant extracts harboring anti-hepatitis c virus ns5b polymerase activity
JP2014218476A (en) * 2013-05-10 2014-11-20 丸善製薬株式会社 Hyaluronidase activity inhibitor, hydrogen peroxide eraser, whitening agent, anti-aging agent and hair tonic
JP2018020990A (en) * 2016-08-05 2018-02-08 共栄化学工業株式会社 External preparation for skin
CN109403026A (en) * 2018-10-31 2019-03-01 嘉兴珠韵服装有限公司 A kind of preparation method of dyeing and finishing technology pretreating reagent
JP2020143132A (en) * 2018-09-14 2020-09-10 丸善製薬株式会社 Claudin-1 production promoter, occludin production promoter, epidermal tight junction protein production promoter in human skin three-dimensional model, and skin barrier hypofunction inhibitor
WO2021084665A1 (en) * 2019-10-30 2021-05-06 株式会社 資生堂 Platelet-derived growth factor (pdgf)-bb production promoter, stem cell stabilizer containing this, and skin anti-aging agent containing these
JP2021191792A (en) * 2020-05-25 2021-12-16 丸善製薬株式会社 TESTOSTERONE 5α-REDUCTASE ACTIVITY INHIBITOR, HAIR PAPILLA CELL PROLIFERATION PROMOTER, OR GLUTATHIONE PRODUCTION PROMOTER

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2110123B1 (en) 2009-03-30 2016-03-23 Shiseido Company, Ltd. Fibroblast proliferator

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1036279A (en) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd Fibroblast proliferation promoting agent containing vegetable extract
KR100330137B1 (en) * 1999-07-16 2002-03-27 복성해 Novel triterpene-series chemical compound capable of inhibiting lipid-peroxidation and process for preparation thereof
JP2001151630A (en) * 1999-11-30 2001-06-05 Kanebo Ltd Cosmetic
US6849278B2 (en) * 2001-11-21 2005-02-01 Universal Biotech Co., Ltd. Method to counter oxidation of LDL, decrease triglyceride or cholesterol and inhibit atherosclerosis using Hibiscus sabdariffa extract
JP2004359632A (en) * 2003-06-06 2004-12-24 Naris Cosmetics Co Ltd External preparation for skin
WO2006106993A1 (en) * 2005-03-31 2006-10-12 Kobayashi Pharmaceutical Co., Ltd. Melanogenesis inhibitor
WO2006106992A1 (en) * 2005-03-31 2006-10-12 Kobayashi Pharmaceutical Co., Ltd. Melanin production inhibitory agent
JP2006306863A (en) * 2005-03-31 2006-11-09 Kobayashi Pharmaceut Co Ltd Melanin formation inhibitor
JP2006347925A (en) * 2005-06-14 2006-12-28 Kyoei Kagaku Kogyo Kk Plant fermentation product and cosmetic containing the same
US7794759B2 (en) 2006-09-06 2010-09-14 Noevir Co., Ltd. Cell activator, collagen production promoter, skin whitening agent, antioxidant agent, antiinflammatory agent, aromatase activity promoter, protease activity promoter, external preparation for skin, and food
WO2008029798A1 (en) * 2006-09-06 2008-03-13 Noevir Co., Ltd. Cell activator, collagen production promoter, skin whitening agent, antioxidant agent, antiinflammatory agent, aromatase activity promoter, protease activity promoter, external preparation for skin, and food
US20130302279A1 (en) * 2012-04-20 2013-11-14 University Of Medicine & Dentistry Of New Jersey Identification of natural plant extracts harboring anti-hepatitis c virus ns5b polymerase activity
US20160213730A1 (en) * 2012-04-20 2016-07-28 Rutgers, The State University Identification of natural plant extracts harboring anti-hepatitis c virus ns5b polymerase activity
JP2014218476A (en) * 2013-05-10 2014-11-20 丸善製薬株式会社 Hyaluronidase activity inhibitor, hydrogen peroxide eraser, whitening agent, anti-aging agent and hair tonic
JP2018020990A (en) * 2016-08-05 2018-02-08 共栄化学工業株式会社 External preparation for skin
JP2020143132A (en) * 2018-09-14 2020-09-10 丸善製薬株式会社 Claudin-1 production promoter, occludin production promoter, epidermal tight junction protein production promoter in human skin three-dimensional model, and skin barrier hypofunction inhibitor
CN109403026A (en) * 2018-10-31 2019-03-01 嘉兴珠韵服装有限公司 A kind of preparation method of dyeing and finishing technology pretreating reagent
WO2021084665A1 (en) * 2019-10-30 2021-05-06 株式会社 資生堂 Platelet-derived growth factor (pdgf)-bb production promoter, stem cell stabilizer containing this, and skin anti-aging agent containing these
JPWO2021084665A1 (en) * 2019-10-30 2021-05-06
JP2021191792A (en) * 2020-05-25 2021-12-16 丸善製薬株式会社 TESTOSTERONE 5α-REDUCTASE ACTIVITY INHIBITOR, HAIR PAPILLA CELL PROLIFERATION PROMOTER, OR GLUTATHIONE PRODUCTION PROMOTER

Also Published As

Publication number Publication date
JP3748941B2 (en) 2006-02-22

Similar Documents

Publication Publication Date Title
JP4572003B2 (en) Use of peptides for scarring, moisturizing and improving skin appearance as cosmetics or as dermatological agents during natural aging or hyperaging (sun dermatitis, contamination)
JPH09295928A (en) Cosmetic material for prevention of aging
JP7200211B2 (en) Compounds useful for the treatment and/or care of skin, hair, nails and/or mucous membranes
US20050187197A1 (en) Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof
KR20100135871A (en) Active ingredient that stimulates the proliferation and/or activity of fibroblasts
KR100361433B1 (en) Anti-aging cosmetic compositions containing an Extract obtained from Panax ginseng
JP2008100943A (en) External preparation for skin having action to promote secretion of insulin-like growth factor 1
KR20110013812A (en) Cosmetic composition containing salicornia herbacea callus extracts and laminaria digitata extracts for improving skin wrinkle or enhancing skin elasticity
JP4891274B2 (en) Biaryl compounds and cosmetics
JP3280903B2 (en) External preparation for skin
JP2003073225A (en) Cosmetic
JP3907856B2 (en) Cosmetics
KR20210060801A (en) Cosmetic Compositions for Anti-aging Comprising Complex Fermented Product of Plants
JP3278138B2 (en) External preparation for skin
KR20130102712A (en) Anti-heat aging effect of fermented limonia acidissima extract and its cosmetic usage to improve skin problems
JP2004067552A (en) Collagen production promoter, and cosmetic containing the same
JP4926455B2 (en) External composition for skin containing rahan fruit extract and sophorolipid
CN111920703B (en) Hyaluronic acid-containing composition for skin care and application thereof
KR102047442B1 (en) Composite for mask pack
JP5366358B2 (en) Agent for acting on skin aging mechanism, anti-aging skin external preparation, and anti-aging method
KR101997231B1 (en) Cosmetic composition containing enzyme-treated honey extract
JP2002029923A (en) Collagen production promoter, elastase activity inhibitor, collagen activity inhibitor and skin cosmetic
JP2009234976A (en) Cell activator and external preparation for skin for antiaging
KR20070111025A (en) Anti-wrinkle cosmetic compositions comprising the extract of phaseolus radiatus as active ingredient
KR101545552B1 (en) Cosmetic composition for whitening containing the extract of fermentative Scutellaria baicalensis by Laetiporus Sulphureus

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040810

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041008

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20051011

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051031

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20051129

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20051130

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081209

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091209

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101209

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111209

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111209

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121209

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121209

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131209

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term